CB
Character Biosciences, Inc.
SEC filingBiotechnology · Jersey City, NJ
Amount raised$8.9Msold at filing
Total offering$19.6M$10.8M still open
Investors in the raise4count reported to the SEC
FiledSep 17, 2025first sale Sep 2, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Reut ShemaDirector
Vivek GaripalliDirector
Mayssa AttarDirector
James KasuboskiDirector
Cheng ZhangExecutive Officer, Director
Peter DiLauraDirector
Jason HaflerDirector
Nick OlsenDirector
Executive officers, directors and promoters as listed on the Form D.